Experimental browser for the Atmosphere
A look at how the incoming Trump administration is shaping up—and how pending litigation could force their hand on abortion questions early in 2025.
Dec 11, 2024, 5:41 PM
{ "uri": "at://did:plc:dgp2kmnnvpw3wt2kgmdf4ux3/app.bsky.feed.post/3ld2cigwju22l", "cid": "bafyreichmhcytry6fpdsu7zsjz62ruxixwvg47mgdakspjtusmhnovhzii", "value": { "text": "A look at how the incoming Trump administration is shaping up—and how pending litigation could force their hand on abortion questions early in 2025.", "$type": "app.bsky.feed.post", "embed": { "$type": "app.bsky.embed.external", "external": { "uri": "https://msmagazine.com/2024/12/09/mifepristone-medication-abortion-drug-trump/", "thumb": { "$type": "blob", "ref": { "$link": "bafkreide2jb54sktaaajfg2y7vwpjy6rpik4yxa2y2tve4ivnt226vp2mm" }, "mimeType": "image/jpeg", "size": 281858 }, "title": "Mifepristone Access, and What Comes Next for the Medication Abortion Drug - Ms. Magazine", "description": "Trump, Project 2025, FDA and HHS, Mifepristone Access, and What Comes Next for the Medication Abortion Drug Mifepristone" } }, "langs": [ "en" ], "createdAt": "2024-12-11T17:41:50.215Z" } }